Agios Pharmaceuticals Lands $33,000,000 Series A Financing

  • Feed Type
  • Date
    7/7/2008
  • Company Name
    Agios Pharmaceuticals
  • Mailing Address
    29 Newbury Street Boston, MA 02116
  • Company Description
    Agios is a biopharmaceutical company at the forefront of one of the most exciting new areas of cancer research: cancer metabolism. Cancer metabolism represents a breakthrough understanding of how cancer cells become addicted to using more nutrients than normal cells to ensure their survival and growth.
  • Website
    http://www.agios.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $33,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    ARCH Venture Partners